Itron
ITRI
225 hedge funds and large institutions have $1.58B invested in Itron in 2013 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 78 increasing their positions, 76 reducing their positions, and 34 closing their positions.
225% more call options, than puts
Call options by funds: $3.33M | Put options by funds: $1.02M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
5% more capital invested
Capital invested by funds: $1.51B → $1.58B (+$73M)
3% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 76
9% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 34
3% less funds holding
Funds holding: 231 → 225 (-6)
Top Buyers
| 1 |
Harris Associates
Chicago,
Illinois
|
+$32.2M |
| 2 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$29.2M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$13.4M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$9.59M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$9.53M |
Top Sellers
ITRI Hedge Fund Activity: Q3 2013 in Review
225 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Itron (ITRI) for Q3 2013, worth a combined $1.58B — up 4.8% from $1.51B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of ITRI and 31 opened new positions — a net loss of 3 holders — while 76 trimmed existing stakes and 78 added.
The largest buyer was Harris Associates, opening a new position worth an estimated $32.2M. The largest seller was Frontier Capital Management, cutting an estimated $30.3M.
- 225 institutional investors held Itron (ITRI) as of Q3 2013, down from 231 in Q2 2013.
- Funds reported $1.58B of Itron stock for Q3 2013, up 4.8% quarter-over-quarter.
- 31 funds opened new Itron positions in Q3 2013 and 34 closed out, a net change of -3 holders.
- The largest Itron buyer in Q3 2013 was Harris Associates, an estimated $32.2M added.
- The largest Itron seller in Q3 2013 was Frontier Capital Management, an estimated $30.3M sold.
Based on aggregated 13F filings for Q3 2013.